Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

Immunotherapies strengthen the body's own anticancer defenses in a highly targeted manner. In therapies using so-called CAR T ...

Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a ...

T cells see only a small sample of the body’s proteins in the thymus, yet a machine learning model shows how they can still ...

Blocking a tumor antioxidant restored T cell activity and made some resistant cancers more responsive to immunotherapy in mice.

A compound drawn from one of the most storied plants in traditional Chinese medicine may hold unexpected power against a rare ...

CAR T-cell therapy has revolutionized treatment for many blood cancers. However, the benefits of its use in the early stages of care remain uncertain. Chimeric antigen receptor (CAR) T-cell therapy ...

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through ...

However, the risk of these rare cancers is not enough to dissuade prescribing CAR T-cell therapy for CLL, explains Kerry Rogers, MD, The James.

In the setting of Alzheimer’s and other neurodegenerative diseases, do T cells make things better, or worse? A simple answer just won’t do—it likely depends on the type of T cells, where they are in ...